Immunogenicity of Recombinant Human Interleukin-3

ISSN： 1521-6616

Source： Clinical Immunology, Vol.83, Iss.1, 1997-04, pp. : 5-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Allergen-Specific Immunotherapy on Recombinant Human Interleukin 3–Mediated Amplification of Allergen-Induced Basophil Histamine Release

By Kowal Krzysztof Nolte Hendrik Skov Per Stahl DuBuske Lawrence M.

Allergy and Asthma Proceedings, Vol. 26, Iss. 6, 2005-11 ,pp. : 456-462

OceanSide Publications, Inc

Access to resources Recommend Favorite

Safety Evaluation of Recombinant Human Interleukin-4 I. Preclinical Studies

By Leach M.W. Snyder E.A. Sinha D.P. Rosenblum I.Y.

Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. : 8-11

Academic Press

Access to resources Recommend Favorite

Prevention of Murine Experimental Autoimmune Orchitis by Recombinant Human Interleukin-6

By Li L. Itoh M. Ablake M. Macrì B. Bendtzen K. Nicoletti F.

Clinical Immunology, Vol. 102, Iss. 2, 2002-02 ,pp. : 135-137

Academic Press

Access to resources Recommend Favorite

Safety Evaluation of Recombinant Human Interleukin-4 II. Clinical Studies

By Leach M.W. Rybak M.E. Rosenblum I.Y.

Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. : 12-14

Academic Press

Access to resources Recommend Favorite

Preclinical Immunogenicity Testing for Recombinant Therapeutic Proteins

By Smith Holly Wierda Daniel

Journal of Immunotoxicology, Vol. 2, Iss. 4, 2005-10 ,pp. : 203-210

Informa Healthcare

Access to resources Recommend Favorite